Can individuals with cervical precancerous lesions receive the cervical cancer vaccine?

Cervical cancer vaccines are, in fact, a class of vaccines designed to prevent cervical cancer by targeting human papillomavirus (HPV). Specifically, they protect against high-risk HPV types that infect the female genital tract, thereby reducing the incidence of cervical cancer. However, if a woman has already developed precancerous cervical lesions, vaccination is not recommended; instead, active treatment of these precancerous lesions is advised.

Cervical precancerous lesions are categorized as either low-grade or high-grade. For low-grade lesions, local ablation techniques—such as laser therapy, microwave therapy, or cryotherapy—can be used to induce necrosis and shedding of the abnormal epithelium, allowing healthy new epithelium to regenerate, thus achieving cure. In contrast, management of high-grade precancerous lesions requires individualized treatment planning based on specific patient factors—for example, age and reproductive desires.

Cervical cancer profoundly impacts women’s physical and mental health. Therefore, prevention prior to lesion development is paramount. Ideally, HPV vaccination should be administered before any precancerous changes occur—even before initiation of sexual activity—and regular cervical cancer screening should be performed routinely. Additionally, maintaining a regular sleep schedule, engaging in regular physical exercise, and strengthening immune function are essential. Avoiding unsafe sexual practices further helps minimize the risk of both cervical cancer and its precancerous lesions.